All News

2017

April

Media Release / Apr 11, 2017

Major Novartis investment in Slovenia reinforces commitment to largest Sandoz product and business

Read More

March

Media Release / Mar 20, 2017

Sandoz digital “Scientific Standalone” event will help drive access to medical information in field of cardiovascular therapies

Read More
Media Release / Mar 13, 2017

Sandoz announces winners of inaugural Healthcare Access Challenge (Sandoz HACk)

Read More
Media Release / Mar 06, 2017

New data demonstrate Sandoz proposed biosimilar adalimumab has equivalent efficacy to reference medicine

Read More

February

Media Release / Feb 08, 2017

Sandoz certified as Top Employer Europe 2017

Read More
Media Release / Feb 07, 2017

Sandoz confirms strategic commitment to drive access to medicines in Japan, with plan to double business by 2022

Read More

January

Media Release / Jan 25, 2017

Novartis delivered solid 2016 performance, with Growth Products[1] absorbing Gleevec US LOE; innovation momentum continued; announces share buyback

Read More
2016

December

Media Release / Dec 05, 2016

New interim data demonstrate Sandoz proposed biosimilar rituximab has equivalent efficacy to reference product

Read More

November

Media Release / Nov 22, 2016

Sandoz to donate up to USD 10 million of high-quality generic medicines annually to Americares to increase access to medicines

Read More
Media Release / Nov 18, 2016

Innovative study with three treatment switches confirms Sandoz biosimilar etanercept has equivalent efficacy to originator

Read More

Pages